Clin2
NCT02402244Possibly a fitRecruiting

Caring registry study for children and young people with cancer

Adrenal Gland PheochromocytomaCarcinoma In SituCentral Nervous System NeoplasmChildhood Immature TeratomaChildhood Kidney NeoplasmChildhood Langerhans Cell HistiocytosisChildhood Mature TeratomaCongenital Mesoblastic Nephroma

Part of Blood & lymphatic, Brain & nervous system, Cancer, Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.

This study keeps a careful record of children, teens, and young adults with cancer (and some related growths) and may follow them over time. It helps researchers better track outcomes and future contact so care can improve.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
75,000 people
Ages
Up to 25 years
Study type
Observational

Who can take part

  • You (or your parent/guardian) can join within 6 months of your first diagnosis or after a later relapse or return of cancer
  • You are 25 or younger when you were first diagnosed (unless you are being screened for a specific COG treatment study with a higher age limit)
  • Your diagnosis is a type of tumor or cancer that fits the study’s list (including most malignant cancers, some borderline/carcinoma-in-situ cases, and all central nervous system and kidney neoplasms)
  • You may also qualify for certain specific “benign” or “borderline” conditions (like teratomas or Langerhans cell histiocytosis)
  • A parent/guardian or you must sign the study consent form (and consent for extra bone marrow is recommended if that procedure is done first)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05192980Recruiting
Register people with certain neuroblastic tumors in an international study

This study creates an international registry linked to a virtual biobank, so researchers can collect and share information and biological samples for patients with specific peripheral neuroblastic tumors. It may help future research and care planning by improving what scientists know about these conditions.

Prague
NCT03067181Recruiting· Phase 3
Active surveillance and chemotherapy for germ cell tumors

This study looks at how to manage germ cell tumors in children and young adults using careful monitoring for some patients and chemotherapy for others. It aims to see whether these approaches can control the cancer while avoiding unnecessary treatment when possible.

Birmingham, Alabama
NCT07246213Recruiting
Childhood cancer survivor research study

This study looks back at the medical records of children and young adults diagnosed with cancer in the last 15 years. It helps researchers understand more about cancer in young people.

Yerevan
NCT07072143Recruiting
Study on children with rare tumors

This study is looking at children and teens with very rare tumors to learn more about these conditions and improve future care. It aims to gather information from patients treated at participating centers.

Padova, Italy
NCT04715178Recruiting
Childhood cancer sample and data registry

This study collects stored samples (like blood or tissue) and health information from people affected by cancer at a young age, including some survivors. The goal is to build a library of specimens and data that researchers can use to better understand childhood and young adult cancers.

Little Rock, Arkansas
NCT00700414Recruiting
Family registry for children with adrenal gland tumors

This study is a registry that collects medical information to better understand adrenal gland tumors in children. It may help researchers learn patterns of these tumors and how they relate to family history.

Stanford, California

Hear when a new Carcinoma in Situ trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.